renovaro - Robuta Search

https://markets.businessinsider.com/news/stocks/renovaro-secures-u-s-patent-for-ai-driven-drug-discovery-diagnostics-platform-1034792323 Renovaro secures U.S. patent for AI-driven drug discovery, diagnostics platform | Markets Insider Renovaro announced that its subsidiary BioSymetrics has received a Notice of Allowance from the United States Patent and Trademark Office for a ... https://markets.businessinsider.com/news/stocks/renovaro-biosciences-secures-multiple-u-s-patents-in-biomedical-ai-1034947467 Renovaro BioSciences secures multiple U.S. patents in biomedical AI | Markets Insider Renovaro announced multiple U.S. patent allowances that significantly strengthen its competitive position in biomedical artificial intelligence.... u s https://markets.businessinsider.com/news/stocks/renovaro-appoints-nathen-fuentes-as-chief-financial-officer-1034200042 Renovaro Appoints Nathen Fuentes as Chief Financial Officer | Markets Insider Senior Biotechnology and Specialty Healthcare Financial Executive Brings Extensive Experience in Leading Acquisition and Organic Growth Initiative... chief financial officer appoints nathen fuentes markets https://markets.businessinsider.com/news/stocks/renovaro-biosciences-inc-trading-halted-news-pending-1035235726 Renovaro Biosciences Inc trading halted, news pending | Markets Insider 19:50 EDT Renovaro Biosciences Inc trading halted, news pendingElevate Your Investing Strategy: Take advantage of TipRanks Premium at 55% off! ... biosciences inc trading news pending https://markets.businessinsider.com/news/stocks/renovaro-biosciences-appoints-fuentes-as-chief-financial-officer-1034201657 Renovaro BioSciences appoints Fuentes as Chief Financial Officer | Markets Insider Renovaro (RENB) announced the appointment of Nathen Fuentes, CPA, as Chief Financial Officer effective January 2, 2025, replacing interim CFO Si... chief financial officer biosciences appoints fuentes markets https://markets.businessinsider.com/news/stocks/renovaro-announces-expedited-trial-on-suit-to-enforce-predictive-oncology-merger-1034756991 Renovaro announces expedited trial on suit to enforce Predictive Oncology merger | Markets Insider Renovaro (RENB) has received a ruling to expedite a trial in 2025 for the lawsuit it filed on May 9, in the Delaware Court of Chancery against P... https://markets.businessinsider.com/news/stocks/renovaro-to-acquire-predictive-oncology-in-all-stock-transaction-1034194684 Renovaro to Acquire Predictive Oncology in All-Stock Transaction | Markets Insider Acquisition provides access to critical resources encompassing a biobank of more than 150,000 tumor specimens, 200,000 pathology slides and decade... all stock acquire predictive oncology https://markets.businessinsider.com/news/stocks/renovaro-secures-key-u-s-patent-to-strengthen-ai-driven-drug-discovery-and-diagnostics-platform-1034790491 Renovaro Secures Key U.S. Patent to Strengthen AI-Driven Drug Discovery and Diagnostics Platform |... Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical MarketsLOS ANGELES, June 03, 2... https://www.renovarogroup.com/ Renovaro Bio AI for Cancer Care | AI Precision Medicine Renovaro revolutionizes cancer and neurology care through early detection, drug discovery, and personalized treatments. AI-powered precision medicine. bio ai cancer care precision medicine https://markets.businessinsider.com/news/stocks/update---renovaro-inc-announces-expedited-trial-for-2025-lawsuit-to-enforce-binding-merger-agreement-with-predictive-oncology-1034756536 UPDATE - Renovaro Inc. Announces Expedited Trial for 2025 Lawsuit to Enforce Binding Merger... LOS ANGELES, May 22, 2025 (GLOBE NEWSWIRE) -- Renovaro Inc. (NASDAQ: RENB), a TechBio leader focused on next-generation diagnostics, drug disco...